Work

Rociletinib, a third generation EGFR tyrosine kinase inhibitor: current data and future directions

Year: 2016

Type: article

Source: Expert Opinion on Pharmacotherapy

DOI: 10.1517/14656566.2016.1162786

Authors: Jody C. Chuang, Ameen A. Salahudeen, Heather A. Wakelee

Institutions: Stanford Health Care, Stanford Medicine, Stanford University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2301090715

FWCI: 2.683

Cites: 23

Cited by: 23

Related to: 10